Ifp Advisors, Inc Neu Base Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$0.13 - $3.05 $13 - $305	100 New	100 $0
Q3 2021 Oct 06, 2021	SELL	$3.27 - $4.76 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$4.63 - $7.34 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$6.92 - $12.36 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$6.92 - $9.25 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$7.25 - $9.71 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$6.69 - $11.51 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$4.77 - $8.23 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$4.5 - $8.1 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$3.15 - $6.59 $0 - $0	0 New	0 $0

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.